Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 138

    1.

    Reuse of single-dose nevirapine in subsequent pregnancies for the prevention of mother-to-child HIV transmission in Lusaka, Zambia: a cohort study.

    Walter J, Kuhn L, Kankasa C, Semrau K, Sinkala M, Thea DM, Aldrovandi GM.

    BMC Infect Dis. 2008 Dec 30;8:172.PMID: 19116004 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effectiveness of repeat single-dose nevirapine for prevention of mother-to-child transmission of HIV-1 in repeat pregnancies in Uganda.

    McConnell M, Bakaki P, Eure C, Mubiru M, Bagenda D, Downing R, Matovu F, Thigpen MC, Greenberg AE, Fowler MG.

    J Acquir Immune Defic Syndr. 2007 Nov 1;46(3):291-6.PMID: 18167645 [PubMed - indexed for MEDLINE]Related articles

    3.

    Mortality and virologic outcomes after access to antiretroviral therapy among a cohort of HIV-infected women who received single-dose nevirapine in Lusaka, Zambia.

    Kuhn L, Semrau K, Ramachandran S, Sinkala M, Scott N, Kasonde P, Mwiya M, Kankasa C, Decker D, Thea DM, Aldrovandi GM.

    J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):132-6.PMID: 19506483 [PubMed - indexed for MEDLINE]Related articles

    4.

    A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.

    Thistle P, Spitzer RF, Glazier RH, Pilon R, Arbess G, Simor A, Boyle E, Chitsike I, Chipato T, Gottesman M, Silverman M.

    Clin Infect Dis. 2007 Jan 1;44(1):111-9. Epub 2006 Nov 22.PMID: 17143826 [PubMed - indexed for MEDLINE]Related articles

    5.

    Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

    Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.

    Clin Infect Dis. 2008 Feb 15;46(4):611-21.PMID: 18197758 [PubMed - indexed for MEDLINE]Related articles

    6.

    Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.

    Lallemant M, Jourdain G, Le Coeur S, Mary JY, Ngo-Giang-Huong N, Koetsawang S, Kanshana S, McIntosh K, Thaineua V; Perinatal HIV Prevention Trial (Thailand) Investigators.

    N Engl J Med. 2004 Jul 15;351(3):217-28. Epub 2004 Jul 9.PMID: 15247338 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Survival in women exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV: a stochastic model.

    Westreich D, Eron J, Behets F, Horst C, Van Rie A.

    J Infect Dis. 2007 Mar 15;195(6):837-46. Epub 2007 Feb 7.PMID: 17299714 [PubMed - indexed for MEDLINE]Related articles

    8.

    Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China.

    Han J, Wang L, Jiang Y, Zhang Q, Fang L, Yao J, Wang Q.

    Int J STD AIDS. 2009 Apr;20(4):249-54.PMID: 19304969 [PubMed - indexed for MEDLINE]Related articles

    9.

    Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.

    Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.

    PLoS Med. 2007 Aug;4(8):e257.PMID: 17713983 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.

    Dorenbaum A, Cunningham CK, Gelber RD, Culnane M, Mofenson L, Britto P, Rekacewicz C, Newell ML, Delfraissy JF, Cunningham-Schrader B, Mirochnick M, Sullivan JL; International PACTG 316 Team.

    JAMA. 2002 Jul 10;288(2):189-98.PMID: 12095383 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Predictors of nonadherence to single-dose nevirapine therapy for the prevention of mother-to-child HIV transmission.

    Albrecht S, Semrau K, Kasonde P, Sinkala M, Kankasa C, Vwalika C, Aldrovandi GM, Thea DM, Kuhn L.

    J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):114-8.PMID: 16340483 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis.

    Arrivé E, Newell ML, Ekouevi DK, Chaix ML, Thiebaut R, Masquelier B, Leroy V, Perre PV, Rouzioux C, Dabis F; Ghent Group on HIV in Women and Children.

    Int J Epidemiol. 2007 Oct;36(5):1009-21. Epub 2007 May 28. Review.PMID: 17533166 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance.

    Martinson NA, Morris L, Johnson J, Gray GE, Pillay V, Ledwaba J, Dhlamini P, Cohen S, Puren A, Steyn J, Heneine W, McIntyre JA.

    AIDS. 2009 Apr 27;23(7):809-16.PMID: 19287298 [PubMed - indexed for MEDLINE]Related articles

    14.

    Transmission rates in consecutive pregnancies exposed to single-dose nevirapine in Soweto, South Africa and Abidjan, Côte d'Ivoire.

    Martinson NA, Ekouevi DK, Dabis F, Morris L, Lupodwana P, Tonwe-Gold B, Dhlamini P, Becquet R, Steyn JG, Leroy V, Viho I, Gray GE, McIntyre JA.

    J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):206-9.PMID: 17438480 [PubMed - indexed for MEDLINE]Related articles

    15.

    Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.

    Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ.

    AIDS. 2008 Sep 12;22(14):1815-20.PMID: 18753864 [PubMed - indexed for MEDLINE]Related articles

    16.

    In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine.

    Church JD, Mwatha A, Bagenda D, Omer SB, Donnell D, Musoke P, Nakabiito C, Eure C, Bakaki P, Matovu F, Thigpen MC, Guay LA, McConnell M, Fowler MG, Jackson JB, Eshleman SH.

    AIDS Res Hum Retroviruses. 2009 Jul;25(7):673-7.PMID: 19552593 [PubMed - indexed for MEDLINE]Related articles

    17.

    Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.

    Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Ducar C, Deseyve M, Emel L, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Dransfield K, Bray D, Mmiro F, Jackson JB.

    Lancet. 1999 Sep 4;354(9181):795-802.PMID: 10485720 [PubMed - indexed for MEDLINE]Related articles

    18.

    Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.

    Dabis F, Bequet L, Ekouevi DK, Viho I, Rouet F, Horo A, Sakarovitch C, Becquet R, Fassinou P, Dequae-Merchadou L, Welffens-Ekra C, Rouzioux C, Leroy V; ANRS 1201/1202 DITRAME PLUS Study Group.

    AIDS. 2005 Feb 18;19(3):309-18.PMID: 15718842 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Determinants of nonadherence to a single-dose nevirapine regimen for the prevention of mother-to-child HIV transmission in Rwanda.

    Delvaux T, Elul B, Ndagije F, Munyana E, Roberfroid D, Asiimwe A.

    J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):223-30.PMID: 19131884 [PubMed - indexed for MEDLINE]Related articles

    20.

    Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

    Brocklehurst P, Volmink J.

    Cochrane Database Syst Rev. 2002;(2):CD003510. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD003510. PMID: 12076484 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data